New Agents for the Treatment of Acute Lymphoblastic Leukemia
New Agents for the Treatment of Acute Lymphoblastic Leukaemia (ALL), examines the strategies for the use of new agents as well as possible targets of therapy in this disease. Though associated with high cure rates, relapsed disease has a poor outcome. Moreover, therapy is unduly prolonged and toxic....
Corporate Author: | SpringerLink (Online service) |
---|---|
Other Authors: | Saha, Vaskar (Editor), Kearns, Pamela (Editor) |
Format: | Electronic eBook |
Language: | English |
Published: |
New York, NY :
Springer New York,
2011.
|
Subjects: | |
Online Access: | Full Text via HEAL-Link |
Similar Items
-
Targeted Therapy of Acute Myeloid Leukemia
Published: (2015) -
Lymphoma and Leukemia of the Nervous System
Published: (2012) -
Vascular Disruptive Agents for the Treatment of Cancer
Published: (2010) -
Cytokines in the Genesis and Treatment of Cancer
Published: (2007) -
Antiangiogenic Agents in Cancer Therapy
Published: (2008)